Delving into the Fraser Institute's Groundbreaking Research on Wait Time Costs

The Fraser Institute's recent study, The Private Cost of Public Queues for Medically Necessary Care, 2026, authored by Senior Policy Analyst Mackenzie Moir and released on March 10, 2026, shines a light on the hidden economic burden borne by Canadian patients due to prolonged healthcare wait times. Drawing from physician surveys and wage data, it reveals that in 2025 alone, approximately 1.386 million Canadians—equivalent to 3.3% of the population—were waiting for treatment following specialist consultations, incurring over $4.2 billion in lost wages and productivity. This figure represents a conservative estimate, focusing solely on work-week hours lost when patients face significant difficulties due to untreated conditions.

At an average of $3,043 per patient, these costs underscore how delays not only affect individual health but also ripple through the economy, reducing workforce participation and output. The study emphasizes that this valuation excludes broader impacts like family caregiving time, mental health strain, or heightened medical risks such as adverse events or mortality during waits.

How Wait Times Are Measured in Canada's Healthcare System

To grasp the study's foundation, it's essential to understand wait times in Canada. The Fraser Institute's companion report, Waiting Your Turn: Wait Times for Health Care in Canada, 2025, surveys over 1,577 physicians across 12 specialties in 10 provinces, capturing median waits from general practitioner (GP) referral to specialist consultation (15.3 weeks nationally in 2025) and from consultation to treatment (13.3 weeks), totaling 28.6 weeks—the second-longest recorded. This is a slight improvement from 30 weeks in 2024 but 208% longer than 9.3 weeks in 1993.

Specialties like neurosurgery (49.9 weeks total) and orthopaedic surgery (48.6 weeks) face the longest delays, while radiation oncology (4.2 weeks) sees shorter queues. Provincially, Ontario leads with 19.2 weeks, while New Brunswick lags at 60.9 weeks. Diagnostic imaging adds further strain: MRI scans average 18.1 weeks, CT scans 8.8 weeks.

Breaking Down the Economic Toll by Province and Specialty

The $4.2 billion national figure masks stark provincial disparities. Quebec bore the highest cost at $1.295 billion, followed by Ontario ($769.9 million) and British Columbia ($584.2 million). Per capita, New Brunswick patients faced $4,864 in losses, compared to Ontario's $1,918.

• Orthopaedic surgery dominated costs in Alberta ($165.5 million) and British Columbia ($130.5 million).
• Ophthalmology led in Ontario ($188.9 million) and Quebec ($143.9 million).
• General surgery topped Nova Scotia ($78 million) and Quebec ($201.7 million).

"Residual" procedures (not directly surveyed) accounted for $1.65 billion, highlighting gaps in data coverage. If valuing all waking hours (excluding sleep), costs balloon to $12.9 billion or $9,336 per patient.Full Fraser Institute report

Historical Trends: A Persistent Challenge Over Decades

Since 2004, inflation-adjusted per-patient costs have risen 58% to $3,043, despite a 9.5% nominal drop from 2024. Wait times peaked in the 2010s but remain elevated, with total procedures waiting steady at around 1.4 million annually. The methodology updates prior estimates using a 13.2% productivity loss rate from Statistics Canada's Canadian Community Health Survey (2003–2013 data), suggesting earlier reports underestimated impacts by about 20%.

This longevity illustrates systemic issues: limited supply of specialists, operating rooms, and beds amid rising demand from an aging population (20% over 65 by 2026).

Photo by Andy Holmes on Unsplash

Contrasting Views: CIHI Data and Official Benchmarks

While Fraser's physician surveys capture broad waits, the Canadian Institute for Health Information (CIHI) tracks priority procedures. In 2024–2025, median waits for hip/knee replacements exceeded pre-2019 levels, with cancer surgeries up 1–5 days (prostatectomy notably longer). Only 60.7% of adults were satisfied with provider wait times, and same/next-day access stood at 26.8%. CIHI notes persistent post-pandemic backlogs, aligning with Fraser but focusing on benchmarks (e.g., 50% within 182 days for joints).CIHI wait times dashboard

Stakeholder Perspectives: Physicians, Patients, and Policymakers

Physicians report waits 4.5 weeks beyond clinically reasonable levels. Patients echo frustration: surveys show 83% desire under three months, yet many endure longer, impacting quality of life. No immediate federal response to the 2026 study, but provinces like Manitoba vow ER/surgery reductions. The Canadian Medical Association (CMA) highlights 5.9 million without primary care, driving specialist overload.

Fraser analyst Moir notes: "As long as lengthy wait times define Canada's health-care system, patients will continue to pay a price in lost time."

Broader Economic and Workforce Implications

Beyond wages, delays exacerbate labor shortages: untreated musculoskeletal issues sideline workers, costing GDP growth. With healthcare comprising 12% of GDP ($330B in 2025), inefficiencies compound fiscal pressures. For researchers analyzing health economics, opportunities abound in policy studies—check research jobs at Canadian universities.

Productivity losses hit sectors like manufacturing and services hardest, where physical demands amplify orthopaedic delays.

Promising Solutions from Experts and Recent Initiatives

The CMA proposes five affordable fixes: physician mobility via multi-jurisdictional licenses, faster international medical graduate (IMG) integration, modern data systems (ditching faxes), AI guidelines, and greener practices. Provinces advance team-based care (e.g., nurse practitioners, pharmacists) and virtual consults. B.C. and Manitoba cut admin burdens; Ontario targets 800,000 more family doctors by 2026.

• Expand IMGs: Streamline credentials for 10,000+ applicants.
• Tech upgrades: Interoperable EHRs could shave weeks.
• Targeted funding: Prioritize high-burden specialties like orthopaedics.

Private clinics for diagnostics (e.g., MRI) show promise without full privatization.CMA's 2026 access plan

Photo by Jean-Luc Picard on Unsplash

Future Outlook: Paths to Shorter Waits and Stronger Productivity

With federal-provincial deals injecting $196B over 10 years, 2026 could see gains if focused on supply (more ORs, staff) and demand management (prevention). University-led research in health policy and AI triage will be pivotal—explore higher ed jobs in health sciences or career advice for policy roles. Ultimately, balancing universal access with efficiency demands innovation, not inertia.

Optimistic signs: 2025's slight dip suggests momentum, but sustained reform is key to reclaiming $4B+ annually. For health researchers and policymakers, platforms like Rate My Professor and university jobs foster talent pipelines. Interested in academia? Post opportunities at higher-ed-jobs or seek higher ed career advice.